3Ps augmenting drug discovery in APAC Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific APAC region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership 3Ps that is moving up the pharmaceutical value chain.